Literature DB >> 24166603

The immunohistochemical expression of CD24 and CD171 adhesion molecules in borderline ovarian tumors.

Alexandra Moulla1, Dimosthenis Miliaras, Antonia Sioga, Aikaterini Kaidoglou, Louisa Economou.   

Abstract

CD24 and CD171 are cell adhesion proteins, which have been shown to be overexpressed in several carcinomas and to be associated with a poor clinical outcome. Our aim was to determine the expression of these two adhesion molecules in ovarian borderline neoplasms. We investigated 50 ovarian borderline tumors (serous, mucinous and endometrioid) as well as 29 benign cystadenomas and 25 carcinomas, which were used as controls. Paraffin sections were stained immunohistochemically for CD24 and CD171, and their expression was recorded in a semi-quantitative manner. In normal epithelium and benign ovarian cystadenomas both the CD24 and CD171 expression was negative to low, while their expression was significantly increased in borderline and malignant ovarian tumors. High-grade carcinomas, and carcinomas with metastases to the omentum presented considerably higher CD24 expression than low-grade carcinomas, and carcinomas without metastases. In addition, a few borderline and many malignant tumors presented cytoplasmic CD24 immunoreactivity, whereas all benign and most borderline tumors showed apical localization of this molecule. In conclusion, borderline tumors and carcinomas of the ovary present increased expression of CD24 and CD171 in relation to their benign counterparts, as is the case in malignant tumors of other organs. Change of staining pattern of CD24 (apical to cytoplasmic) apparently relates to a more aggressive phenotype.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24166603     DOI: 10.5114/pjp.2013.38135

Source DB:  PubMed          Journal:  Pol J Pathol        ISSN: 1233-9687            Impact factor:   1.072


  7 in total

Review 1.  Ovarian cancer stem cells: Can targeted therapy lead to improved progression-free survival?

Authors:  Christen L Walters Haygood; Rebecca C Arend; J Michael Straughn; Donald J Buchsbaum
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

2.  Expression of L1 protein correlates with cluster of differentiation 24 and integrin β1 expression in gastrointestinal stromal tumors.

Authors:  Yue DU; Haihong Zhang; Zhongmin Jiang; Guowei Huang; Wenli Lu; Hesheng Wang
Journal:  Oncol Lett       Date:  2015-04-02       Impact factor: 2.967

3.  Role of CD24 in anoikis resistance of ovarian cancer cells.

Authors:  Yan-Hui Li; Xiang Sun; Hong-Bo Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

4.  CD24 promotes HCC progression via triggering Notch-related EMT and modulation of tumor microenvironment.

Authors:  Xin Wan; Ci Cheng; Qing Shao; Zhe Lin; Shuai Lu; Yun Chen
Journal:  Tumour Biol       Date:  2015-11-25

5.  Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer.

Authors:  Samira Abdel Azim; Michaela Duggan-Peer; Susanne Sprung; Daniel Reimer; Heidi Fiegl; Afschin Soleiman; Christian Marth; Alain G Zeimet
Journal:  Oncotarget       Date:  2016-06-14

6.  Ovarian function and ovarian blood supply following premenopausal abdominal hysterectomy.

Authors:  Ibrahim A Abdelazim; Khaled M Abdelrazak; Assem A M Elbiaa; Mohamed M Farghali; Amr Essam; Gulmira Zhurabekova
Journal:  Prz Menopauzalny       Date:  2015-12-08

7.  TGF-β1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation.

Authors:  Donatella Delle Cave; Martina Di Guida; Valerio Costa; Marta Sevillano; Luigi Ferrante; Christopher Heeschen; Marco Corona; Antonio Cucciardi; Enza Lonardo
Journal:  Oncogene       Date:  2020-04-14       Impact factor: 9.867

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.